Insiders / Kiener Peter A
Kiener Peter A
CIK 1328146personinsider
Companies
3
First seen
Jan 6, 2021
Last activity
Jan 6, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Cue Biopharma, Inc. · CUE | 357 | — |
| LAVA Therapeutics NV · LVTX | — | — |
| Palvella Therapeutics, Inc. · PIRS | — | — |
All securities held
5 positions · latest reported per filing
Shares
| Company | Security | Shares |
|---|---|---|
| Cue Biopharma, Inc. | Common stock | 357 |
Derivatives
| Company | Security | Shares |
|---|---|---|
| Cue Biopharma, Inc. | Options | 24,400 |
| Palvella Therapeutics, Inc. | Options | 40,000 |
Other
| Company | Security | Shares |
|---|---|---|
| Cue Biopharma, Inc. | Unclassified | 24,400 |
| Palvella Therapeutics, Inc. | Unclassified | 40,000 |
Ownership percentages elsewhere on the site count common and ordinary shares only, because that is what shares outstanding are measured in. Everything above is a real holding; not all of it is a share of the company.
Activity
InsidersInstitutions
This person's trades in company stock, across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Nov 15, 2021 | Sell Open-market sale | CUE Cue Biopharma, Inc. Common Stock | $337.2K | -19K -100.00% | 0 0.00% of shares | medium |
| Nov 15, 2021 | Exercise Option exercise | CUE Cue Biopharma, Inc. Common Stock | $53.8K | +19K | 18,815 0.47% of shares | low |
| Mar 23, 2023 | Sell Open-market sale | CUE Cue Biopharma, Inc. Common Stock | $30.6K |